Brian Greffe
- Neurology top 5%
- Neuroblastoma Research and Treatments 7
-
- Childhood Cancer Survivors' Quality of Life 7
- Rheumatology top 5%
- Pathology and Forensic Medicine top 10%
- Lymphoma Diagnosis and Treatment 5
-
- Sarcoma Diagnosis and Treatment 11
-
- Testicular diseases and treatments 6
-
- Renal and related cancers 4
-
- Viral-associated cancers and disorders 3
-
- Hepatocellular Carcinoma Treatment and Prognosis 3
- Co-authors
- Ann MertensMarilyn StovallNeyssa MarinaLeslie RobisonCharles A. SklarJohn WhittonDaniel J. GreenGary W. Mierau
- Journals
- Journal of Pediatric Hematology/Oncology (6 papers)Journal of Clinical Oncology (5 papers)Pediatric Blood & Cancer (4 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Brian Greffe
41 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 89
- Neurology 275
- Pediatrics, Perinatology and Child Health 312
- Rheumatology 198
- Pathology and Forensic Medicine 199
- Pulmonary and Respiratory Medicine 343
Countries citing papers authored by Brian Greffe
This map shows the geographic impact of Brian Greffe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Greffe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Greffe more than expected).
Fields of papers citing papers by Brian Greffe
This network shows the impact of papers produced by Brian Greffe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Greffe. The network helps show where Brian Greffe may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Brian Greffe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 9 | |
| 2 | 2021 | 0 | |
| 3 | 2017 | 15 | |
| 4 | 2016 | 3 | |
| 5 | 2016 | 16 | |
| 6 | 2015 | 11 | |
| 7 | 2011 | 21 | |
| 8 | 2011 | 4 | |
| 9 | 2010 | 6 | |
| 10 | 2007 | 6 | |
| 11 | 2006 | 182 | |
| 12 | 2006 | 103 | |
| 13 | 2003 | 83 | |
| 14 | 2000 | 277 | |
| 15 | 1999 | 53 | |
| 16 | 1995 | 17 | |
| 17 | 1994 | 13 | |
| 18 | 1989 | 8 | |
| 19 | 1986 | 25 | |
| 20 | [Appearance of metronidazole resistance in Bacteroides fragilis]. | 1977 | 1 |
About Brian Greffe
Brian Greffe is a scholar working on Neurology, Pulmonary and Respiratory Medicine and Pediatrics, Perinatology and Child Health, having authored 42 papers that have together received 1.3k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (11 papers), Childhood Cancer Survivors' Quality of Life (7 papers), Neuroblastoma Research and Treatments (7 papers), Testicular diseases and treatments (6 papers), Lymphoma Diagnosis and Treatment (5 papers), Renal and related cancers (4 papers), Viral-associated cancers and disorders (3 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). The work is most often cited by research in Neurology (275 citations), Pediatrics, Perinatology and Child Health (312 citations) and Rheumatology (198 citations). Brian Greffe has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Ann Mertens, Marilyn Stovall, Neyssa Marina, Leslie Robison, Charles A. Sklar, John Whitton, Daniel J. Green, Gary W. Mierau, Mark A. Lovell and Leslie L. Robison. Their work appears in journals such as Journal of Pediatric Hematology/Oncology, Journal of Clinical Oncology, Pediatric Blood & Cancer, Cancer and International Journal of Radiation Oncology*Biology*Physics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.